These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes]. Чопей ІВ; Івачевська ВВ; Чубірко КІ; Гряділь ТІ; Гечко ММ Wiad Lek; 2017; 70(2):169-173. PubMed ID: 28511152 [TBL] [Abstract][Full Text] [Related]
24. Pathological features of fatty liver disease. Yeh MM; Brunt EM Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884 [TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. Ahmed A; Wong RJ; Harrison SA Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097 [TBL] [Abstract][Full Text] [Related]
26. Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? Sakhuja P World J Gastroenterol; 2014 Nov; 20(44):16474-9. PubMed ID: 25469015 [TBL] [Abstract][Full Text] [Related]
27. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. Polanco-Briceno S; Glass D; Stuntz M; Caze A BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270 [TBL] [Abstract][Full Text] [Related]
28. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. Dongiovanni P; Romeo S; Valenti L Biomed Res Int; 2015; 2015():460190. PubMed ID: 26273621 [TBL] [Abstract][Full Text] [Related]
29. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. Kanwar P; Kowdley KV Clin Liver Dis; 2016 May; 20(2):225-43. PubMed ID: 27063266 [TBL] [Abstract][Full Text] [Related]
30. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104 [TBL] [Abstract][Full Text] [Related]
31. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. Qamar AA J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961 [TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
34. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Watanabe S; Hashimoto E; Ikejima K; Uto H; Ono M; Sumida Y; Seike M; Takei Y; Takehara T; Tokushige K; Nakajima A; Yoneda M; Saibara T; Shiota G; Sakaida I; Nakamuta M; Mizuta T; Tsubouchi H; Sugano K; Shimosegawa T; ; J Gastroenterol; 2015 Apr; 50(4):364-77. PubMed ID: 25708290 [TBL] [Abstract][Full Text] [Related]
35. Perspectives on Treatment for Nonalcoholic Steatohepatitis. Lassailly G; Caiazzo R; Pattou F; Mathurin P Gastroenterology; 2016 Jun; 150(8):1835-48. PubMed ID: 26971824 [TBL] [Abstract][Full Text] [Related]
36. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438 [TBL] [Abstract][Full Text] [Related]
37. Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis. Lankarani KB; Alavian SM Gastroenterology; 2015 Dec; 149(7):1987-8. PubMed ID: 26515490 [No Abstract] [Full Text] [Related]